0.55
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DRRX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.565
Offen:
$0.53
24-Stunden-Volumen:
48,611
Relative Volume:
0.46
Marktkapitalisierung:
$17.07M
Einnahmen:
$8.59M
Nettoeinkommen (Verlust:
$-17.07M
KGV:
-0.9016
EPS:
-0.61
Netto-Cashflow:
$-21.90M
1W Leistung:
+3.73%
1M Leistung:
-20.52%
6M Leistung:
-34.61%
1J Leistung:
-66.67%
Durect Corp Stock (DRRX) Company Profile
Firmenname
Durect Corp
Sektor
Telefon
(408) 777-1417
Adresse
10240 BUBB ROAD, CUPERTINO, CA
Vergleichen Sie DRRX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
DRRX
Durect Corp
|
0.55 | 16.46M | 8.59M | -17.07M | -21.90M | -0.61 |
![]()
ZTS
Zoetis Inc
|
151.19 | 68.05B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.58B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.65 | 43.71B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.40B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
297.89 | 13.23B | 2.99B | 1.21B | 1.13B | 25.06 |
Durect Corp Stock (DRRX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2020-10-30 | Eingeleitet | Chardan Capital Markets | Buy |
2020-10-12 | Eingeleitet | ROTH Capital | Buy |
2020-07-31 | Eingeleitet | Oppenheimer | Outperform |
2020-01-31 | Eingeleitet | B. Riley FBR | Buy |
2019-11-18 | Fortgesetzt | Cantor Fitzgerald | Overweight |
2019-09-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
2018-03-06 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2017-10-20 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2017-10-20 | Bestätigt | Laidlaw | Buy |
2017-10-20 | Herabstufung | Stifel | Buy → Hold |
2017-07-12 | Hochstufung | Stifel | Hold → Buy |
2017-02-28 | Fortgesetzt | H.C. Wainwright | Buy |
2016-04-25 | Eingeleitet | Rodman & Renshaw | Buy |
2015-05-01 | Bestätigt | Cantor Fitzgerald | Buy |
2015-05-01 | Bestätigt | Stifel | Buy |
2013-03-25 | Eingeleitet | Stifel | Buy |
2012-11-01 | Herabstufung | C.K. Cooper | Buy → Hold |
2012-08-17 | Eingeleitet | C.K. Cooper | Buy |
2009-06-23 | Eingeleitet | Caris & Company | Buy |
2009-03-26 | Eingeleitet | Wedbush Morgan | Hold |
Alle ansehen
Durect Corp Aktie (DRRX) Neueste Nachrichten
DURECT Corporation Stock Analysis and ForecastFree Bull & Bear Market Updates - Autocar Professional
Indus Towers Limited (INDUSTOWER) vs yyyLightning-fast capital gains - jammulinksnews.com
Is GOLD a good long term investmentSuperior stock selection - jammulinksnews.com
What drives Sizzle Acquisition Corp. II Debt Equity Composite Units stock priceFree Stock Market Trend Analysis - jammulinksnews.com
Best Banking Stocks to Buy Expert Investment InsightsPhenomenal wealth increase - Autocar Professional
Best Technology Stocks in India Short Term Profit StocksFastest return on investment - Autocar Professional
QuickLogic Corporation Stock Analysis and ForecastRapid portfolio appreciation - jammulinksnews.com
Is Investcorp AI Acquisition Corp. Equity Warrant a good long term investmentAccelerated capital growth - printweek.in
Is BH.A a good long term investmentFree Stock Movement Tracking - jammulinksnews.com
Is ESLA a good long term investmentExceptional risk-adjusted gains - Autocar Professional
Dhanada Corporation Limited (531198) Quarterly Results Are OutRapid-fire capital growth - jammulinksnews.com
why ivda stock attracts strong analyst attentionFree Access to Community with 300% Return - Newser
Is DURECT Corporation a good long term investmentUnstoppable trading performance - Autocar Professional
Churchill Capital Corp IX Debt Equity Composite Units Stock Analysis and ForecastRapid-fire capital growth - Jammu Links News
Best Indian Stocks for Capital Protection Expert Chosen Financial InsightsFree Investment Case Studies - jammulinksnews.com
VLYPN Stock Analysis and ForecastFree Stock Chart Pattern Guide - jammulinksnews.com
What analysts say about Precision Optics Corporation Inc. stockRecord-breaking capital gains - jammulinksnews.com
Top Reasons to Buy OAX(oax)Weekly Big Movers - Newser
Top Agricultural Stocks Best Investment Portfolio IdeasExplosive earnings growth - Jammu Links News
BAC(basis cash) Project ReviewFree Stock Market Trend Analysis - Newser
What drives DURECT Corporation stock priceDouble or triple returns - jammulinksnews.com
What analysts say about DURECT Corporation stockExceptional portfolio growth - jammulinksnews.com
Why DURECT Corporation stock attracts strong analyst attentionFree Stock Investment Growth Plan - Newser
What makes Rush Street Interactive Inc. stock price move sharplyFree Investment Portfolio Suggestions - Newser
What makes DURECT Corporation stock price move sharplyHigh Reward Risk Balanced Trading - Newser
How DURECT Corporation stock performs during market volatilitySmart Money Trade Setups - Newser
What makes Maywood Acquisition Corp. Equity Right stock price move sharplyReal Chart Play - Newser
How BBAR stock performs during market volatilitySmart Money Signals - Newser
Why CXDO stock attracts strong analyst attentionSafe High Return Entry Points - Newser
YUANG(yuang coin) Price TodayStable Growth Stock Picks - Newser
How Pasithea Therapeutics Corp. Equity Warrant stock performs during market volatilityInsider Level Guidance - beatles.ru
Allay’s $57.5M extends postsurgical pain relief with ATX-101 - BioWorld MedTech
Jane Street Group LLC Purchases 28,486 Shares of DURECT Co. (NASDAQ:DRRX) - Defense World
Durect Corp stock hits 52-week low at $0.52 amid market challenges - Investing.com Australia
Durect Corp stock hits 52-week low at $0.52 amid market challenges By Investing.com - Investing.com South Africa
Durect says on July 24, Impax Laboratories terminated asset transfer and license agreement dated Jan. 3, 2014 - Reuters
DURECT (NASDAQ:DRRX) Now Covered by Analysts at StockNews.com - Defense World
Pre-market Movers: NRXS, EYEN, TIL, HCTI, EKSO... - RTTNews
Durect: Q1 Earnings Snapshot - New Haven Register
DURECT (DRRX) Q1 Revenue Surpasses Estimates, Focuses on Phase 3 Trial Funding | DRRX Stock News - GuruFocus
Finanzdaten der Durect Corp-Aktie (DRRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):